Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.30 HKD
Change Today -0.02 / -6.25%
Volume 1.2M
8197 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

northeast tiger pharma co -h (8197) Snapshot

Open
$0.31
Previous Close
$0.32
Day High
$0.33
Day Low
$0.30
52 Week High
04/8/15 - $0.39
52 Week Low
03/23/15 - $0.19
Market Cap
224.0M
Average Volume 10 Days
6.1M
EPS TTM
$-0.04
Shares Outstanding
207.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NORTHEAST TIGER PHARMA CO -H (8197)

Related News

No related news articles were found.

northeast tiger pharma co -h (8197) Related Businessweek News

No Related Businessweek News Found

northeast tiger pharma co -h (8197) Details

Northeast Tiger Pharmaceutical Co., Ltd., an investment holding company, develops, manufactures, processes, and sells medicines under the Northeast Tiger brand name in the People’s Republic of China. It is also involved in the breeding, processing, and sale of Chinese medicine herbs, including underground ginseng, asarum, acanthopanax, fritillaria ussuriensis maxim, fragrant solomonseal rhizome, and forest frog. The company was founded in 1998 and is based in Central, Hong Kong.

22 Employees
Last Reported Date: 03/23/15
Founded in 1998

northeast tiger pharma co -h (8197) Top Compensated Officers

General Manager, Compliance Officer and Execu...
Total Annual Compensation: --
Chairman
Total Annual Compensation: CNY25.0K
Executive Director
Total Annual Compensation: CNY25.0K
Compensation as of Fiscal Year 2013.

northeast tiger pharma co -h (8197) Key Developments

Northeast Tiger Pharmaceutical Co. Ltd. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Northeast Tiger Pharmaceutical Co. Ltd. reported audited consolidated earnings results for the year ended December 31, 2014. For the period, turnover was RMB 0.029 million against RMB 0.005 million a year ago. Loss before income tax expense was RMB 26.708 million against profit before income tax expense of RMB 6.659 million a year ago. Loss and total comprehensive income attributable to owners of the company was RMB 26.708 million or 3.58 cents per basic share against profit and total comprehensive income attributable to owners of the company of RMB 6.659 million or 0.89 cents per basic share a year ago.

Northeast Tiger Pharmaceutical Co. Ltd. Provides Earnings Guidance for the Year Ended December 31, 2014

Northeast Tiger Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2014. For the period, the company may record a significant decrease in net profit and will record loss as compared to that of the corresponding period in 2013.

Northeast Tiger Pharmaceutical Co. Ltd. to Report Fiscal Year 2014 Results on Mar 06, 2015

Northeast Tiger Pharmaceutical Co. Ltd. announced that they will report fiscal year 2014 results on Mar 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8197:HK $0.30 HKD -0.02

8197 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8197.
View Industry Companies
 

Industry Analysis

8197

Industry Average

Valuation 8197 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6,187.5x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5,065.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHEAST TIGER PHARMA CO -H, please visit www.northeasttiger.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.